255 related articles for article (PubMed ID: 26152202)
1. Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.
McDonell LM; Kernohan KD; Boycott KM; Sawyer SL
Hum Mol Genet; 2015 Oct; 24(R1):R60-6. PubMed ID: 26152202
[TBL] [Abstract][Full Text] [Related]
2. Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis.
Hu H; Liu Y; Jiang T
Tumour Biol; 2015 Mar; 36(3):1423-8. PubMed ID: 25750036
[TBL] [Abstract][Full Text] [Related]
3. Feedback regulation of RTK signaling in development.
Neben CL; Lo M; Jura N; Klein OD
Dev Biol; 2019 Mar; 447(1):71-89. PubMed ID: 29079424
[TBL] [Abstract][Full Text] [Related]
4. Mislocalisation of Activated Receptor Tyrosine Kinases - Challenges for Cancer Therapy.
Schmidt-Arras D; Böhmer FD
Trends Mol Med; 2020 Sep; 26(9):833-847. PubMed ID: 32593582
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic Cleavage of Receptor Tyrosine Kinases.
Huang H
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947097
[TBL] [Abstract][Full Text] [Related]
6. Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations.
Gallo LH; Nelson KN; Meyer AN; Donoghue DJ
Cytokine Growth Factor Rev; 2015 Aug; 26(4):425-49. PubMed ID: 26003532
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic lymphoma kinase in human cancer.
Barreca A; Lasorsa E; Riera L; Machiorlatti R; Piva R; Ponzoni M; Kwee I; Bertoni F; Piccaluga PP; Pileri SA; Inghirami G;
J Mol Endocrinol; 2011 Aug; 47(1):R11-23. PubMed ID: 21502284
[TBL] [Abstract][Full Text] [Related]
8. TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.
Pierce AM; Keating AK
Brain Res; 2014 Jan; 1542():206-20. PubMed ID: 24184575
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of receptor tyrosine kinase activation in cancer.
Du Z; Lovly CM
Mol Cancer; 2018 Feb; 17(1):58. PubMed ID: 29455648
[TBL] [Abstract][Full Text] [Related]
10. Roles of fibroblast growth factor receptors in carcinogenesis.
Haugsten EM; Wiedlocha A; Olsnes S; Wesche J
Mol Cancer Res; 2010 Nov; 8(11):1439-52. PubMed ID: 21047773
[TBL] [Abstract][Full Text] [Related]
11. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.
Matalkah F; Martin E; Zhao H; Agazie YM
Breast Cancer Res; 2016 Jan; 18(1):2. PubMed ID: 26728598
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.
Haxho F; Neufeld RJ; Szewczuk MR
Oncotarget; 2016 Jun; 7(26):40860-40881. PubMed ID: 27029067
[TBL] [Abstract][Full Text] [Related]
13. Receptor tyrosine kinases: from biology to pathology.
Choura M; Rebaï A
J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163
[TBL] [Abstract][Full Text] [Related]
14. All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.
Margiotta A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198477
[TBL] [Abstract][Full Text] [Related]
15. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases.
Abella JV; Park M
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E973-84. PubMed ID: 19240253
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine phosphatase Shp2 in development and cancer.
Grossmann KS; Rosário M; Birchmeier C; Birchmeier W
Adv Cancer Res; 2010; 106():53-89. PubMed ID: 20399956
[TBL] [Abstract][Full Text] [Related]
17. Interplay between receptor tyrosine kinases and hypoxia signaling in cancer.
Glück AA; Aebersold DM; Zimmer Y; Medová M
Int J Biochem Cell Biol; 2015 May; 62():101-14. PubMed ID: 25747905
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase receptors as attractive targets of cancer therapy.
Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
20. Receptor tyrosine kinase signalling as a target for cancer intervention strategies.
Zwick E; Bange J; Ullrich A
Endocr Relat Cancer; 2001 Sep; 8(3):161-73. PubMed ID: 11566607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
